临床病理学分析和预后因素的生存患者与可手术的脉冲性癌症:一个多机构的回顾性经验
Nebi Serkan Demirci1, Eyyup Cavdar2, Nuriye Yildirim Ozdemir3
1Department of Medical Oncology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098 Istanbul, Türkiye.
Medicina (Kaunas, Lithuania)
|May 25, 2024
概括
节点状况和积极的外科手术边缘是囊癌患者生存率低下的关键预测因素. 需要进一步的研究,以了解辅助疗法的作用,以改善这些患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 尽管获得了最佳治疗,但脉冲性癌症的存活率仍然低于最佳 (30-50%在5年内).
- 确定预后因素对于改善可手术的囊癌的结果至关重要.
研究的目的:
- 确定影响预后的显著临床病理特征.
- 评估辅助治疗在可手术的囊癌患者中的作用.
主要方法:
- 对197名因囊癌而接受胰腺二切除术的患者进行了回顾性分析.
- 评估人口统计,临床特征,治疗和生存结果.
主要成果:
- 多变量分析确定了节点状态 (HR 1.98) 和积极的外科边缘 (HR 2.61) 作为减少整体存活 (OS) 的独立预测因素.
- 淋巴血管侵袭和淋巴结的参与显著影响了无病生存率 (DFS).
- 单变量分析揭示了与下降的OS相关的多个因素,包括年龄,表现状况,体重减轻,瘤阶段,边缘状况,结节状况,淋巴血管入侵,围神经入侵和组织学等级.
结论:
- 节点状况和积极的外科手术边缘是囊癌总生存率降低的独立预后指标.
- 对辅助疗法的进一步研究是有必要的,以提高生存率.
相关概念视频
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177


